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Message from the Director
Dear Colleagues:
At the beginning of 2012, 
the U.S. Centers 
for Disease Control 
and Prevention 






as a result, the 
Division of Global Health Protection (DGHP) 
was established and has now been officially 
approved as an entity within CGH.
DGHP draws upon the expertise of subject 
matter experts from within the division and 
from across the agency to provide assistance 
to Ministries of Health around the world. The 
Division’s mission is to improve the health and 
well-being of Americans and other people 
around the world. We look to accomplish this 
work by promoting the advancement of strong 
public health systems and ensuring global 
health security.
As the first permanent Director of DGHP, I 
am excited about the opportunity to provide 
leadership and overall strategic direction for the 
Division’s activities and ensure that our work is 
aligned with CDC’s strategic objectives.
Since coming to CDC as an Epidemic 
Intelligence Service (EIS) Officer in 1992, I 
have served in a range of leadership positions 
at CDC headquarters in Atlanta, Georgia, as 
well as in Botswana, including serving as 
CDC Country Director in both Thailand and 
Uganda. Prior to accepting the DGHP Director 
position, I served as Director of CDC’s Health 
Systems Reconstruction Office (HRSO) from 
2010-2012, supporting post-earthquake public 
health recovery activities in Haiti, including 
emergency response for epidemic cholera.   
From January through November 2013, I served 
as the Associate Director for Science, CGH.  
These experiences have given me tremendous 
insight and hands-on experience with the 
public health challenges we face on a daily 
basis and in times of crisis. 
While we have made significant strides 
in improving public health globally, I am 
confident that in the months and years ahead, 
working together we can make even greater 
improvements in helping countries build core 
capacities to prevent disease, disability and 
death from emerging and reemerging infectious 
diseases, natural and man-made disasters and 
non-communicable diseases. 
As we come to the close of 2013, I want to thank 
our staff in the U.S. and around the globe for 
their hard work and commitment to helping 
partner countries build essential systems to 
meet their own public health priorities and 
requirements of the International Health 
Regulations. I also want to thank our partners 
and subject matter experts both within CDC 
and beyond; your support has been critical to 
the progress we have made in improving health 
globally. Finally, I would like to recognize the 
many ministries of health, academic institutions, 
and other external organizations we work with 
in the U.S. and around the world and reconfirm 
our commitment to working with you to improve 
public health and ensure global health security. 
I wish you and your families a peaceful and 
healthy holiday season and look forward to 
working with you in 2014.
— Capt. (USPHS) Jordan W. Tappero, MD, MPH   
Director, Division of Global Health Protection 
Center for Global Health                                                               
U.S. Centers for Disease Control and Prevention
—Capt. Jordan W. Tappero, MD, MPH
Seeking Submissions…
If you would like your program to 
be featured in an upcoming issue of 
Updates from the Field, please send 
a 200-400 word summary of your 
program’s activities and photos to 
Ruth Cooke Gibbs at icn6@cdc.gov.
www.cdc.gov/globalhealth Updates from the Field: Winter 2013, Issue 13 2 of 8
Highlights of Investigations
Angola FELTP Respond to Country’s First Identified 
Dengue Epidemic
Submitted by: Dr. Rosa Moreira, Resident Advisor, Angola FELTP 
In March 2013, two patients complaining of headache, fever, and rash were admitted to a hospital in Luanda, the coastal capital city of Angola. When their health declined, they were 
evacuated to Portugal for further management. Specimens 
from both patients were sent to Portugal’s Institute of Tropical 
Diseases for analysis, and test results confirmed both patients had 
dengue. Dengue, caused by any one of four related viruses that 
are transmitted by mosquitoes, has emerged as a leading cause of 
illness and death in the tropics and subtropics affecting as many 
as 400 million people yearly. There is neither a vaccine to prevent 
infection nor medications to treat people with dengue. The most 
effective way to prevent infection is to avoid mosquito bites. When 
infected, early recognition and prompt supportive treatment can 
substantially lower the risk of developing severe disease.
Because this was the first time dengue had been detected in 
Angola, the National Directorate of Hygiene and Epidemiology 
within the Angola Ministry of Health (MOH), reached out to the 
Angola Field Epidemiology and Laboratory Training Program 
(A-FELTP) for assistance. In response, Drs. Maria Jose Soares 
and Luis Miguel Costa, A-FELTP residents, accompanied by two 
members of the surveillance staff from the Province of Luanda, 
were deployed to conduct an outbreak investigation.
Drs. Soares and Costa visited the Luanda General Hospital and 
learned that patients from a construction company had been 
admitted to the company’s Health Center with symptoms 
compatible with dengue: headache, fever, exhaustion, severe joint 
and muscle pain, swollen glands and rash. Blood samples were 
taken from all six patients and immediately transported to the 
reference laboratory. However, they soon encountered a problem:  
since dengue was not previously known to be a public health 
problem in Angola, the laboratory did not have the capability 
to test for dengue. Fortunately, Dr. Luis Miguel from the Angola 
FELTP remembered seeing some dengue rapid test kits when 
he was organizing a laboratory in the nearby province of Lunda 
Norte during a malaria 
outbreak. He contacted 
the laboratory staff and 
asked them to send the 
test kits to Luanda. 
Once the tests arrived, 
Dr. Luis Miguel tested 
the patients’ samples; 
four of six were positive 
for dengue. The MOH 
responded immediately 
by purchasing dengue 
rapid tests and 
launching a community 
outreach campaign to 
alert the public and all 
Health Units about the dengue outbreak and how to prevent the 
virus from spreading. In accordance with International Health 
Regulations, the MOH also notified the World Health Organization 
(WHO) and reached out to the U.S. Centers for Disease Control 
and Prevention (CDC) for assistance. CDC responded by providing 
research support and training to control the outbreak. Specimens 
from additional cases were sent to the Pasteur Institute in Dakar, 
Senegal, and CDC’s Dengue Branch in Puerto Rico for confirmatory 
diagnostic testing. Results of this analysis confirmed that the 
outbreak was caused by a Dengue virus that has been circulating 
in western-central Africa over the past 45 years. This indicated that 
dengue has been endemic in the region for several decades, but 
likely under recognized clinically and misdiagnosed as malaria. 
According to the Angola MOH, as of August 29, 1,207 cases of 
dengue have been reported nationwide, of which 806 (67%) 
tested positive with a rapid diagnostic test. Of the 1,207 cases, 
nearly all occurred in the province of Luanda, although Kwanza 
Sul Province reported 16 cases in Sumbe, and Uige Province 
reported one case in Uige-Sede. The total number of rapid test-
positive, dengue-associated fatalities was 11, all of which were 
reported from Luanda Province. 
This is the first time that Angola has confirmed a dengue 
epidemic. In response, FELTP residents with the support of 
CDC’s Dengue Branch conducted a household survey in Luanda, 
provided training for health workers (clinicians, nurses and lab 
technicians), conducted mosquito surveillance to identify the 
most abundant mosquito species and breeding sites, and carried 
out a community health education outreach campaign to 
educate the public about dengue. FELTP residents are continuing 
surveillance and analysis of findings and will provide a full report 
and recommendations to the MOH on dengue prevention 
measures to prevent or limit the morbidity and mortality 
associated with future dengue epidemics.
For further information, please contact Dr. Augusto Lopez at 
acl9@cdc.gov.
Angola FELTP Resident, Dr. Luis Miguel and first 
responders from the Provincial Health Department 
of Luanda and Chinese Health Officers conducting 
interviews and taking blood samples from patients 
in Angola during dengue outbreak.
Angola-FELTP residents preparing for field work during the Dengue Survey. 
(Left to Right) C.Teixeira, M. Jose Soares, L. Costa, J. Paixao,C. Sicato, 
J. Manuel, P. Lussukamu.
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Highlights of Investigations
CDC Assists with First Reported Outbreak of Chikungunya 
virus in Yap State, Federated States of Micronesia
Submitted by: Serena Fuller, MPH, Emergency Coordinator, and Susan 
Hills, MD, MPH Medical Epidemiologist, CDC
In October 2013, clinicians in Yap State, Federated States of Micronesia, noticed an increase in the number of patients presenting with fever, rash, and joint pain. Yap has had previous 
dengue outbreaks, but samples from the current outbreak tested 
negative for dengue by rapid diagnostic test. Nevertheless, 
the epidemiology and clinical symptoms suggested a possible 
mosquito-borne disease. 
On October 17, CDC received a request for assistance from Yap and 
samples were shipped to the Division of Vector-Borne Diseases 
(DVBD) in Fort Collins, Colorado.  While an etiology was being 
sought via laboratory testing, CDC worked on logistics to deploy a 
team of epidemiologists. Because there are only two flights to Yap 
each week, DVBD acted quickly with support from the Emergency 
Operations Center and Global Disease Detection Operations Center 
to deploy three staff, including two Epidemic Intelligence Service 
Officers and one medical epidemiologist. After four flights and 
more than 24 hours in transit, they arrived in Yap to assist with 
describing the epidemiology of the outbreak and developing 
recommendations for prevention and control. 
Shortly after their arrival, laboratory testing confirmed that 
the current outbreak was caused by Chikungunya virus, which 
allowed refinement of the case definition and a shift in clinical 
management and response activities. Chikungunya virus was first 
identified in East Africa and has since caused outbreaks on islands 
in the Indian Ocean, Asia, and now the Western Pacific. This is the 
first outbreak in Micronesia. With no prior exposure or immunity, 
attack rates will likely be very high and may involve a majority of 
the island’s population. Although Chikungunya has lower mortality 
than dengue, it causes substantial morbidity and joint pain can 
persist for weeks or months. Chikungunya virus prevention consists 
of measures to prevent mosquitoes from biting people including 
personal protection efforts (window screens, bed nets, and 
repellents), measures to empty or eliminate containers where the 
mosquitoes breed, and use of insecticides. Yap State health officials 
are coordinating vector control efforts with regional partners.
After Chikungunya virus was identified as the cause of the 
outbreak, two DVBD entomologists traveled to Yap to identify the 
vector species and advise on vector control. Aedes aegypti, the 
mosquito species that usually transmits Chikungunya virus, is not 
widespread in Yap, but Aedes hensilli, another potential vector 
mosquito, is common on the islands. 
Meanwhile, the team already in Yap was forced to evacuate to 
Guam in advance of Typhoon Haiyan. They returned to Yap with the 
entomologists on November 9. The effect of the typhoon on the 
outbreak remains to be seen.
To be continued….
For further information, please contact Susan Hills, MD, MPH at  
hri1@cdc.gov
Dr. Holly Biggs and Dr. Dan Pastula, Division of Vector-Borne Diseases EIS 
officers, unpacking larvicide and insect repellent. 
Planning meeting during the Chikungunya virus outbreak on Yap, Micronesia.
Radio interview with Dr. Thane Hancock, Physician, Yap, and Dr. Dan Pastula, 
EIS officer, to disseminate Chikungunya prevention messages.
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Partnership Matters
CDC Responds to Public Health Emergency in Syria
Submitted by: Julia Smith-Easley and Dr. Lisa Gargano, CDC  
CDC’s Emergency Response and Recovery Branch (ERRB) is responsible for implementing and coordinating CDC’s response to complex 
humanitarian emergencies like the civil conflict taking 
place in Syria. The 28-months-old conflict has led to the 
displacement of a third of Syria’s population. Fighting 
throughout the country has displaced 7 million Syrians 
with many living in overcrowded, unsanitary conditions. 
A third of all hospitals are reportedly closed. The United 
Nations (UN) reports more than 92,000 fatalities. This 
year has seen an increase in the number of Syrian 
refugees crossing international borders. According to 
The Office of the UN High Commissioner for Refugees 
(UNHCR), there are over 2 million refugees in Lebanon, 
Jordan, Turkey, Iraq, and Egypt. Every day, thousands of 
new refugees continue to enter bordering countries. 
To respond to the immediate and long-term public health needs 
of those affected by crises, CDC draws upon expertise across the 
agency to work with partners. Efforts focus on activities such as 
national laboratory and surveillance systems; water, sanitation 
and hygiene interventions; mental health; reproductive health 
and emergency obstetrical care; and infectious disease control 
programs. Thus far, ERRB’s efforts in Syria include:
 • Working with U.S. Agency for International Development’s   
(USAID) Disaster Assistance Response Team in Turkey to provide 
technical support and bolster the disease surveillance system 
for the polio response in Syria. ERRB experts are also working 
in CDC’s Emergency Operations Center and with the USAID 
Response Management Team in Washington, DC to provide 
support for the polio response;
 • Conducting needs assessments and providing recommendations 
to UNHCR about a surveillance, outbreak alert and response 
system to address the complexities of health care delivery 
inside the Za’atari refugee camp in Jordan, as well as helping to 
implement an Early Warning and Response Network (EWARN) 
surveillance system to detect and respond to potential disease 
outbreaks;
 • Assisting with the response to a measles outbreak and 
developing a strategy to detect suspected cases of tuberculosis 
among Syrian refugees; 
 • Assessing reproductive health needs to help prevent excess 
newborn and maternal morbidity and mortality; reduce HIV 
transmission; prevent and manage the consequences of sexual 
violence; and plan for comprehensive reproductive health services; 
 • Providing training in epidemiologic and public health methods to 
humanitarian aid workers from countries in the region;
 • Serving as UN Children’s Fund (UNICEF) health advisor in the 
Za’atari refugee camp to coordinate and supervise UNICEF’s child 
health, immunization, diarrheal disease control, and newborn 
care programs; 
 • Supervising coordination and planning of a health and 
hygiene campaign and developing plans for increasing 
capacity for routine vaccination. ERRB is also assessing weekly 
vaccination and supervising oral rehydration corners at six 
different health care centers; and
 • Collaborating with the International Medical Corps (IMC) to 
conduct an outcome study of IMC’s mental health program in 
Jordan for Syrian and Iraqi refugees
A full report detailing ERRB activities in Syria will be available 
in 2014. Learn more about CDC’s global health efforts at http://
www.cdc.gov/globalhealth.
For further information, please contact:  Julia Smith-Easley at 
zrc2@cdc.gov.
Zaa’tari Camp welcome sign, March 2013.
Women and children waiting for services at the Maternal and Child Health Clinic, 
Zaa’tari Camp, March 2013
Reproductive Health Facility, Zaa’tari Camp, March 2013.
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Partnership Matters
Improving Public Health Management for Action 
(IMPACT): A new program at CDC
Submitted by Shelly Bratton, MPH, and Alannah Kittle, CDC  
The tools of public health have advanced rapidly in recent years with the development of improved 
vaccines, drugs, diagnostic tests, interventions, 
communications, and transportation.  These 
advancements have made it increasingly 
more complex for managers to implement 
many of the public health programs.  A gap 
exists due to a shortage of middle and senior 
public health officials with the management 
skills needed to run programs and health 
systems and improve the necessary processes 
for effective operations. Without effective 
management and organizational performance, 
many important global health initiatives fall short of 
their goals.  The development of CDC’s Improving Public 
Health Management for Action (IMPACT) program will 
advance health agendas by developing highly trained 
managers who will partner with scientists to ensure that 
the newest tools of public health are most effectively 
used to improve outcomes.
In the same way that CDC extended the Epidemic 
Intelligence Service approach worldwide through the 
Field Epidemiology Training Program (FETP), CDC is 
developing the IMPACT training program to create 
a group of mid-level public health management 
professionals. Similar to CDC’s public health advisors, 
the IMPACT program will train professionals to manage 
health programs within their respective countries. The 
managers will be capable of working across health-related 
areas such as HIV/AIDS, tuberculosis, malaria prevention 
and control, polio eradication, other vaccine-preventable 
diseases, reproductive health, health promotion and education, 
non-communicable disease prevention and control, and 
emergency preparedness. In addition, the managers will 
partner with scientists and technical experts to ensure that 
large investments in global public health are used to improve 
outcomes and strengthen health systems.   
The Bill and Melinda Gates Foundation has funded a one year 
planning grant that will allow CDC, in partnership with the CDC 
Foundation, to lay the foundation for the IMPACT program. In 
the first year of IMPACT, CDC will:
1. Determine the management needs and priorities among 
Ministries of Health; 
2. Evaluate existing global public health management training 
programs; and
3. Design a pilot program for preparing mid-level managers for 
implementation in year two.
According to Dr. William Foege, former Director of 
the CDC, “In 60 years this will be the same kind 
of signature program as the Epidemic Intelligence 
Service and will address one of the major barriers 
in global health today – the gap between the tools 
available and the delivery of those tools.”  
 CDC’s model will differ from existing management training 
models by leveraging our unique advantage of engaging 
government-to-government with a focus on developing long-
term, sustainable programs owned by ministries of health 
(MOH). CDC will work with MOHs on a comprehensive approach 
through the IMPACT program to develop effective managers 
who turn ideas into action and ensure that programs are 
accountable and effective.
For further information, please contact: Shelly Bratton at 
bwp8@cdc.gov.
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Disease Prevention
CDC, PAHO and other global partners move forward with 
the Global Standardized Hypertension Treatment Project 
Submitted by Pragna Patel, MD MPH.
Non-communicable diseases (NCDs) are responsible for almost three quarters of all deaths worldwide. These include deaths caused by injuries such as motor vehicle 
injuries, and chronic 





diseases.  High blood 
pressure, also called 
hypertension, is a 
leading risk factor for 
cardiovascular disease 
and is responsible 
for over nine million 
preventable deaths 
globally each year. 
According to Dr. Sonia 
Angell, Chief of the  
Non-Communicable Disease Unit in CDC’s Center for Global Health 
(CGH), Division of Global Health Protection   and CGH’s Senior 
Advisor for Global NCDs, “The broad-scale control of hypertension 
is challenging for all countries across the income spectrum, yet 
we have models that demonstrate it is possible and feasible 
– including in low- and middle-income countries.” Successful 
treatment of hypertension involves the prescription, availability, 
and adherence to appropriate medications, and sustained long-
term monitoring and adjustment of medications. Conditions that 
impede hypertension control include complex treatment regimens, 
limited availability and affordability of medications, and health care 
systems that are overburdened and under-resourced. 
To address the growing challenges with hypertension control 
globally, CDC in collaboration with the Pan American Health 
Organization (PAHO) and other partners, is launching the Global 
Standardized Hypertension Treatment Project. This project 
involves the development and implementation of a framework 
for standardizing the medical treatment of hypertension. The 
framework was inspired by successful treatment models for 
infectious diseases such as those applied in global tuberculosis and 
HIV management. Central elements include a structured treatment 
approach with a core set of medications, treatment protocols with 
targets, and patient cohort monitoring. The project design aims 
to be feasible and flexible so it can be applied worldwide and 
complement existing hypertension guidelines. 
Project development will first focus on the Latin American and 
Caribbean region. In March 2013, CDC and PAHO convened 
experts, including physicians, pharmacologists, epidemiologists, 
and other leadership from ministries of health, professional 
organizations, and institutions in the region to support the 
development of the framework for improving hypertension 
control worldwide. Key components include:
 • Medication Treatment: Identification of a core set of 
medications appropriate for the treatment of most adults with 
hypertension.
 • Availability of Core Medications: Identification of mechanisms 
to increase the broad scale availability of the core set of 
medications. For the Latin American and Caribbean region, 
the PAHO Strategic Fund recently added to its Medicine List 
additional medications from the core set identified during the 
March workshops (www.paho.org\strategicfund). 
 • Key Elements of Care Delivery: Recommendations for key 
elements of care delivery to support effective hypertension 
treatment.  
In the ensuing months,  CDC in collaboration with regional and 
global partners will develop a plan to broaden stakeholder 
engagement and continually invite contributions to refine 
the approach.  CGH NCD Unit and colleagues are starting 
implementation work with interested countries in the LAC 
region. Lessons learned will inform global dissemination of the 
framework to improve hypertension control worldwide.
For further information about the Global Standardized 
Hypertension Treatment Project and to engage in 
implementation of the framework, please contact Pragna 
Patel, MD, MPH at plp3@cdc.gov.
Global Standardized Hypertension Treatment Project Workshop participants, March 2013, Miami, Florida.
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Training and Resources
CDC’s new non-communicable disease training materials 
are now available online
Submitted by Sharmily Roy 
Non-communicable diseases (NCDs) are responsible for almost 40 million deaths each year, which represents almost three quarters of all deaths worldwide. These 
include injuries caused by road traffic, and chronic diseases, 
such as cardiovascular disease, cancer, diabetes, and chronic 
respiratory diseases.   CDC is addressing the global burden of 
NCDs through various efforts, and has developed a series of 
NCD training materials, which are now available online and can 
be viewed and downloaded from CDC’s Field Epidemiology 
Training Program (FETP) website at http://www.cdc.gov/
globalhealth/fetp/ncd_modules.htm.
FETPs are typically a two year, in-service training program 
modeled after the U.S. Epidemic 
Intelligence Service, an applied 
epidemiology training program created by 
CDC in 1951. Since 1980, CDC has worked 
with ministries of health and other partners 
to establish 50 FETPs serving 69 countries. 
FETPs emphasize practical experience, with 
residents spending less than 25% of their 
time in the classroom and the remaining 
75% or more of their time conducting 
field work under the supervision and 
guidance of an experienced mentor. 
The new NCD training materials have 
been incorporated into the FETP NCD 
curriculum and are designed to increase 
capacity in NCD epidemiology, surveillance 
and management.  Components of the 
curriculum have also been used in short 
courses for non-FETP audiences (e.g., district 
level health officers). 
There are a total of 24 training modules which include facilitator 
and participant guides, PowerPoint slides, as well as other user 
aides. Topics include: analyzing large datasets, evaluating public 
health programs, and developing a protocol.  
These training materials were designed to build NCD capacity 
globally, particularly in low- and middle-income countries, where 
the number of people affected by NCDs is growing and access 
to resources to manage and control the diseases are limited. 
The modules were pilot tested with the FETPs in Jordan, China, 
Columbia, Kenya, Tanzania, and Thailand.  
CDC supports global NCD capacity by:
 • Strengthening national and global disease surveillance;
 • Scaling up the implementation of evidence-based measures to 
reduce risk factors associated with NCDs; and
 • Promoting models that improve management and treatment 
of NCDs.
NCD Modules at Work
In Tanzania, Dr. Faraja Lyamuya, a FETP training participant, 
used the new NCD training materials along with mentorship 
from subject matter experts to conduct a field project aimed at 
improving issues of access related to diabetes management at a 
community clinic supported by the Dodoma Regional hospital 
in Tanzania. Through qualitative and quantitative research, Dr. 
Lyamuya found a high number of patients without adequate 
glucose control, which leads to complications. Following the 
completion of a survey, Dr. Lyamuya made several evidence-
based recommendations to the hospital administrators related 
to diabetes management, such as case management, increased 
availability of subsidized oral hypoglycemic drugs, which are 
known to improve adherence, and patient education. Her 
recommendations were later implemented in the hospital. 
The next steps are to fully implement and evaluate the impact of 
the NCD curriculum and subsequent field activities undertaken 
by FETP residents.  
For further information, please contact Sharmily Roy at 
sgroy@cdc.gov.  
FETP residents and Ministry of Health (MOH) partners testing an online lifestyles 
monitoring system, at the Pasto Center in Colombia, 2012.
Participants of the Tobacco Control Strategy Meeting with community leaders in Pasto, Columbia, 2012. 
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Training and Resources
Nigeria FELTP hosts malaria workshop in Abuja to address 
gaps in malaria research
Submitted by: Patrick Nguku, MD, Resident Advisor, Nigeria Field 
Epidemiology and Laboratory Training Program (NFELTP) 
Since its inception in 2008, the Nigeria Field Epidemiology and Laboratory Training Program (NFELTP) has assisted in numerous disease surveillance evaluations and outbreak 
responses throughout the country. Several NFELTP projects have 
specifically focused on malaria, including research studies in which 
NFELTP graduates and NFELTP residents conducted evaluations of 
malaria surveillance systems at different levels of the health system, 
evaluations of malaria laboratory diagnostic tools and services, and 
analysis of  malaria surveillance data. Current NFELTP residents are 
conducting several research projects involving malaria including 
assessing whether health care providers are adhering to the national 
malaria policy and treatment guidelines, evaluating the accuracy 
of malaria diagnostic tools, estimating household costs of malaria, 
determining the relationship between malaria infection and CD4 
(cells in the immune system) counts among persons living with HIV/
AIDS, identifying reasons for the non-use of insecticide treated nets, 
and assessing the burden of malaria following spraying the inside of 
homes with insecticides.
While past research projects have resulted in valuable information, 
there is a need to allign the NFELTP’s malaria studies 
with current national  research priorities of the National 
Malaria Elimination Program. Until now, there has been 
a gap between the academic requirements of NFELTP 
training and the priority research needs of the Nigerian 
National Malaria Elimination Program (NMEP). At this 
crucial stage, there is a need to bridge the existing gap 
and create a platform that will assist NFELTP residents 
in identifying topics for their research projects that are 
in line with identified national research priorities. 
In order to address these concerns, a scientific 
seminar was held in September 2013 with the theme 
‘Strengthening NFELTP Malaria-Related Research’ at 
the NFELTP training facility in Abuja, Nigeria. The goal 
of the seminar was to encourage and assist NFELTP 
residents in developing malaria-related relevant research 
projects as part of their training. 
The seminar was attended by 30 first and second year NFELTP 
residents.  The outcome of the Nigeria Malaria Indicator Survey 
and the list of prioritized research topics of NMEP were presented. 
Key note speakers from the University of Calabar (Malaria Case 
Management and Malaria in Pregnancy), Ahmadu Bello University 
(Health Economics), University of Ilorin (Vector Control), University 
of Ibadan (Socio-Behavioural Science) and CDC Atlanta (Malaria 
Surveillance) identified research areas with gaps in knowledge 
where residents could chose to focus.  Topics ranged from Malaria 
Case Management, Malaria in Pregnancy, Malaria Surveillance, and 
Vector Control to the Socio-Behavioral Science and Economics 
of Malaria Control. Experts from CDC and other U.S. agencies 
helped mentor residents during the workshop. The workshop was 
coordinated by Dr. Fawole, academic coordinator NFELTP and Dr. 
Olufemi Ajumobi, NFELTP graduate and Epidemiologist National 
Malaria Elimination Program.
At the end of the 3-day workshop, the participants identified an 
inventory of relevant research topics that can be implemented by 
NFELTP residents. Draft research proposals were developed and 
opportunities for networking and collaboration among residents 
and stakeholders were created. 
This workshop was useful in ensuring that NFELTP continues to 
contribute to national malaria research priorities.
For further information, please contact, Dr. Patrick Nguku at 
NgukuP@ng.cdc.gov   
Nigeria FELTP residents engage in group discussions about research gaps in malaria 
research during workshop in Abuja, Nigeria, September 2013. 
Dr. Sola Oresanya presenting at the malaria workshop, 23 – 25 September 2013. 
Participants of the Nigeria FELTP workshop on Strengthening NFELTP Malaria-Related Research, 
September, 2013, Abuja, Nigeria. 
